Global Nucleic Acids for Molecular Diagnosis Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Nucleic Acids for Molecular Diagnosis market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
Nucleic acids for molecular diagnosis refer to the use of DNA or RNA molecules to detect, identify, or quantify specific genetic sequences associated with diseases, pathogens, or other biological conditions. Molecular diagnosis using nucleic acids is a cornerstone of modern diagnostics, offering highly sensitive and specific methods for identifying genetic mutations, infectious agents, and other molecular markers.
This report is a detailed and comprehensive analysis for global Nucleic Acids for Molecular Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nucleic Acids for Molecular Diagnosis market size and forecasts, in consumption value ($ Million), 2020-2031
Global Nucleic Acids for Molecular Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Nucleic Acids for Molecular Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Nucleic Acids for Molecular Diagnosis market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nucleic Acids for Molecular Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nucleic Acids for Molecular Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher Corporation, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Kaneka Eurogentec S.A., Aji Bio-Pharma, L.G.C Biosearch Technologies, Integrated DNA Technologies, Bio-synthesis Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Nucleic Acids for Molecular Diagnosis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nucleic Acids for Molecular Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acids for Molecular Diagnosis, with revenue, gross margin, and global market share of Nucleic Acids for Molecular Diagnosis from 2020 to 2025.
Chapter 3, the Nucleic Acids for Molecular Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Nucleic Acids for Molecular Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acids for Molecular Diagnosis.
Chapter 13, to describe Nucleic Acids for Molecular Diagnosis research findings and conclusion.
Nucleic acids for molecular diagnosis refer to the use of DNA or RNA molecules to detect, identify, or quantify specific genetic sequences associated with diseases, pathogens, or other biological conditions. Molecular diagnosis using nucleic acids is a cornerstone of modern diagnostics, offering highly sensitive and specific methods for identifying genetic mutations, infectious agents, and other molecular markers.
This report is a detailed and comprehensive analysis for global Nucleic Acids for Molecular Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nucleic Acids for Molecular Diagnosis market size and forecasts, in consumption value ($ Million), 2020-2031
Global Nucleic Acids for Molecular Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Nucleic Acids for Molecular Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Nucleic Acids for Molecular Diagnosis market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nucleic Acids for Molecular Diagnosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nucleic Acids for Molecular Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher Corporation, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Kaneka Eurogentec S.A., Aji Bio-Pharma, L.G.C Biosearch Technologies, Integrated DNA Technologies, Bio-synthesis Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Nucleic Acids for Molecular Diagnosis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- DNA Series
- RNA Series
- Infectious Diseases
- Early Cancer Screening
- Blood Screening
- Genetic Diseases
- Genome Sequencing
- Other
- Danaher Corporation
- Merck KGaA
- Eurofins Scientific SE
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Kaneka Eurogentec S.A.
- Aji Bio-Pharma
- L.G.C Biosearch Technologies
- Integrated DNA Technologies
- Bio-synthesis Inc.
- metabion
- QIAGEN
- Hongene
- Synthgene
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nucleic Acids for Molecular Diagnosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acids for Molecular Diagnosis, with revenue, gross margin, and global market share of Nucleic Acids for Molecular Diagnosis from 2020 to 2025.
Chapter 3, the Nucleic Acids for Molecular Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Nucleic Acids for Molecular Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acids for Molecular Diagnosis.
Chapter 13, to describe Nucleic Acids for Molecular Diagnosis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acids for Molecular Diagnosis by Type
1.3.1 Overview: Global Nucleic Acids for Molecular Diagnosis Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type in 2024
1.3.3 DNA Series
1.3.4 RNA Series
1.4 Global Nucleic Acids for Molecular Diagnosis Market by Application
1.4.1 Overview: Global Nucleic Acids for Molecular Diagnosis Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infectious Diseases
1.4.3 Early Cancer Screening
1.4.4 Blood Screening
1.4.5 Genetic Diseases
1.4.6 Genome Sequencing
1.4.7 Other
1.5 Global Nucleic Acids for Molecular Diagnosis Market Size & Forecast
1.6 Global Nucleic Acids for Molecular Diagnosis Market Size and Forecast by Region
1.6.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Region, (2020-2031)
1.6.3 North America Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.4 Europe Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.6 South America Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Danaher Corporation
2.1.1 Danaher Corporation Details
2.1.2 Danaher Corporation Major Business
2.1.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product and Solutions
2.1.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Danaher Corporation Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Product and Solutions
2.2.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Eurofins Scientific SE
2.3.1 Eurofins Scientific SE Details
2.3.2 Eurofins Scientific SE Major Business
2.3.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product and Solutions
2.3.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Eurofins Scientific SE Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
2.4.1 Thermo Fisher Scientific Inc. Details
2.4.2 Thermo Fisher Scientific Inc. Major Business
2.4.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.4.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 Agilent Technologies, Inc.
2.5.1 Agilent Technologies, Inc. Details
2.5.2 Agilent Technologies, Inc. Major Business
2.5.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.5.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.6 Kaneka Eurogentec S.A.
2.6.1 Kaneka Eurogentec S.A. Details
2.6.2 Kaneka Eurogentec S.A. Major Business
2.6.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.6.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Kaneka Eurogentec S.A. Recent Developments and Future Plans
2.7 Aji Bio-Pharma
2.7.1 Aji Bio-Pharma Details
2.7.2 Aji Bio-Pharma Major Business
2.7.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product and Solutions
2.7.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Aji Bio-Pharma Recent Developments and Future Plans
2.8 L.G.C Biosearch Technologies
2.8.1 L.G.C Biosearch Technologies Details
2.8.2 L.G.C Biosearch Technologies Major Business
2.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
2.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
2.9 Integrated DNA Technologies
2.9.1 Integrated DNA Technologies Details
2.9.2 Integrated DNA Technologies Major Business
2.9.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
2.9.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Integrated DNA Technologies Recent Developments and Future Plans
2.10 Bio-synthesis Inc.
2.10.1 Bio-synthesis Inc. Details
2.10.2 Bio-synthesis Inc. Major Business
2.10.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.10.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Bio-synthesis Inc. Recent Developments and Future Plans
2.11 metabion
2.11.1 metabion Details
2.11.2 metabion Major Business
2.11.3 metabion Nucleic Acids for Molecular Diagnosis Product and Solutions
2.11.4 metabion Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 metabion Recent Developments and Future Plans
2.12 QIAGEN
2.12.1 QIAGEN Details
2.12.2 QIAGEN Major Business
2.12.3 QIAGEN Nucleic Acids for Molecular Diagnosis Product and Solutions
2.12.4 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 QIAGEN Recent Developments and Future Plans
2.13 Hongene
2.13.1 Hongene Details
2.13.2 Hongene Major Business
2.13.3 Hongene Nucleic Acids for Molecular Diagnosis Product and Solutions
2.13.4 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hongene Recent Developments and Future Plans
2.14 Synthgene
2.14.1 Synthgene Details
2.14.2 Synthgene Major Business
2.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Product and Solutions
2.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Synthgene Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Nucleic Acids for Molecular Diagnosis Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Nucleic Acids for Molecular Diagnosis by Company Revenue
3.2.2 Top 3 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
3.2.3 Top 6 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
3.3 Nucleic Acids for Molecular Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acids for Molecular Diagnosis Market: Region Footprint
3.3.2 Nucleic Acids for Molecular Diagnosis Market: Company Product Type Footprint
3.3.3 Nucleic Acids for Molecular Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Nucleic Acids for Molecular Diagnosis Consumption Value and Market Share by Type (2020-2025)
4.2 Global Nucleic Acids for Molecular Diagnosis Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2025)
5.2 Global Nucleic Acids for Molecular Diagnosis Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
6.2 North America Nucleic Acids for Molecular Diagnosis Market Size by Application (2020-2031)
6.3 North America Nucleic Acids for Molecular Diagnosis Market Size by Country
6.3.1 North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
6.3.2 United States Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
6.3.3 Canada Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
6.3.4 Mexico Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
7.2 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
7.3 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country
7.3.1 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
7.3.2 Germany Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.3 France Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.5 Russia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.6 Italy Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Region
8.3.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2031)
8.3.2 China Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.3 Japan Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.4 South Korea Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.5 India Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.7 Australia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
9.2 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
9.3 South America Nucleic Acids for Molecular Diagnosis Market Size by Country
9.3.1 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
9.3.2 Brazil Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
9.3.3 Argentina Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country
10.3.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
10.3.2 Turkey Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
10.3.4 UAE Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Nucleic Acids for Molecular Diagnosis Market Drivers
11.2 Nucleic Acids for Molecular Diagnosis Market Restraints
11.3 Nucleic Acids for Molecular Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Nucleic Acids for Molecular Diagnosis Industry Chain
12.2 Nucleic Acids for Molecular Diagnosis Upstream Analysis
12.3 Nucleic Acids for Molecular Diagnosis Midstream Analysis
12.4 Nucleic Acids for Molecular Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acids for Molecular Diagnosis by Type
1.3.1 Overview: Global Nucleic Acids for Molecular Diagnosis Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type in 2024
1.3.3 DNA Series
1.3.4 RNA Series
1.4 Global Nucleic Acids for Molecular Diagnosis Market by Application
1.4.1 Overview: Global Nucleic Acids for Molecular Diagnosis Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Infectious Diseases
1.4.3 Early Cancer Screening
1.4.4 Blood Screening
1.4.5 Genetic Diseases
1.4.6 Genome Sequencing
1.4.7 Other
1.5 Global Nucleic Acids for Molecular Diagnosis Market Size & Forecast
1.6 Global Nucleic Acids for Molecular Diagnosis Market Size and Forecast by Region
1.6.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Region, (2020-2031)
1.6.3 North America Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.4 Europe Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.6 South America Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Danaher Corporation
2.1.1 Danaher Corporation Details
2.1.2 Danaher Corporation Major Business
2.1.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product and Solutions
2.1.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Danaher Corporation Recent Developments and Future Plans
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Product and Solutions
2.2.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck KGaA Recent Developments and Future Plans
2.3 Eurofins Scientific SE
2.3.1 Eurofins Scientific SE Details
2.3.2 Eurofins Scientific SE Major Business
2.3.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product and Solutions
2.3.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Eurofins Scientific SE Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
2.4.1 Thermo Fisher Scientific Inc. Details
2.4.2 Thermo Fisher Scientific Inc. Major Business
2.4.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.4.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 Agilent Technologies, Inc.
2.5.1 Agilent Technologies, Inc. Details
2.5.2 Agilent Technologies, Inc. Major Business
2.5.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.5.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.6 Kaneka Eurogentec S.A.
2.6.1 Kaneka Eurogentec S.A. Details
2.6.2 Kaneka Eurogentec S.A. Major Business
2.6.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.6.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Kaneka Eurogentec S.A. Recent Developments and Future Plans
2.7 Aji Bio-Pharma
2.7.1 Aji Bio-Pharma Details
2.7.2 Aji Bio-Pharma Major Business
2.7.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product and Solutions
2.7.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Aji Bio-Pharma Recent Developments and Future Plans
2.8 L.G.C Biosearch Technologies
2.8.1 L.G.C Biosearch Technologies Details
2.8.2 L.G.C Biosearch Technologies Major Business
2.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
2.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
2.9 Integrated DNA Technologies
2.9.1 Integrated DNA Technologies Details
2.9.2 Integrated DNA Technologies Major Business
2.9.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
2.9.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Integrated DNA Technologies Recent Developments and Future Plans
2.10 Bio-synthesis Inc.
2.10.1 Bio-synthesis Inc. Details
2.10.2 Bio-synthesis Inc. Major Business
2.10.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
2.10.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Bio-synthesis Inc. Recent Developments and Future Plans
2.11 metabion
2.11.1 metabion Details
2.11.2 metabion Major Business
2.11.3 metabion Nucleic Acids for Molecular Diagnosis Product and Solutions
2.11.4 metabion Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 metabion Recent Developments and Future Plans
2.12 QIAGEN
2.12.1 QIAGEN Details
2.12.2 QIAGEN Major Business
2.12.3 QIAGEN Nucleic Acids for Molecular Diagnosis Product and Solutions
2.12.4 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 QIAGEN Recent Developments and Future Plans
2.13 Hongene
2.13.1 Hongene Details
2.13.2 Hongene Major Business
2.13.3 Hongene Nucleic Acids for Molecular Diagnosis Product and Solutions
2.13.4 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hongene Recent Developments and Future Plans
2.14 Synthgene
2.14.1 Synthgene Details
2.14.2 Synthgene Major Business
2.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Product and Solutions
2.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Synthgene Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Nucleic Acids for Molecular Diagnosis Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Nucleic Acids for Molecular Diagnosis by Company Revenue
3.2.2 Top 3 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
3.2.3 Top 6 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
3.3 Nucleic Acids for Molecular Diagnosis Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acids for Molecular Diagnosis Market: Region Footprint
3.3.2 Nucleic Acids for Molecular Diagnosis Market: Company Product Type Footprint
3.3.3 Nucleic Acids for Molecular Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Nucleic Acids for Molecular Diagnosis Consumption Value and Market Share by Type (2020-2025)
4.2 Global Nucleic Acids for Molecular Diagnosis Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2025)
5.2 Global Nucleic Acids for Molecular Diagnosis Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
6.2 North America Nucleic Acids for Molecular Diagnosis Market Size by Application (2020-2031)
6.3 North America Nucleic Acids for Molecular Diagnosis Market Size by Country
6.3.1 North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
6.3.2 United States Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
6.3.3 Canada Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
6.3.4 Mexico Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
7.2 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
7.3 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country
7.3.1 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
7.3.2 Germany Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.3 France Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.5 Russia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
7.3.6 Italy Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Region
8.3.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2031)
8.3.2 China Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.3 Japan Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.4 South Korea Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.5 India Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
8.3.7 Australia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
9.2 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
9.3 South America Nucleic Acids for Molecular Diagnosis Market Size by Country
9.3.1 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
9.3.2 Brazil Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
9.3.3 Argentina Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country
10.3.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
10.3.2 Turkey Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
10.3.4 UAE Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Nucleic Acids for Molecular Diagnosis Market Drivers
11.2 Nucleic Acids for Molecular Diagnosis Market Restraints
11.3 Nucleic Acids for Molecular Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Nucleic Acids for Molecular Diagnosis Industry Chain
12.2 Nucleic Acids for Molecular Diagnosis Upstream Analysis
12.3 Nucleic Acids for Molecular Diagnosis Midstream Analysis
12.4 Nucleic Acids for Molecular Diagnosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 6. Danaher Corporation Major Business
Table 7. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 8. Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Danaher Corporation Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 13. Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. Eurofins Scientific SE Company Information, Head Office, and Major Competitors
Table 16. Eurofins Scientific SE Major Business
Table 17. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 18. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 20. Thermo Fisher Scientific Inc. Major Business
Table 21. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 22. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 24. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 25. Agilent Technologies, Inc. Major Business
Table 26. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 27. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 29. Kaneka Eurogentec S.A. Company Information, Head Office, and Major Competitors
Table 30. Kaneka Eurogentec S.A. Major Business
Table 31. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 32. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Kaneka Eurogentec S.A. Recent Developments and Future Plans
Table 34. Aji Bio-Pharma Company Information, Head Office, and Major Competitors
Table 35. Aji Bio-Pharma Major Business
Table 36. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 37. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Aji Bio-Pharma Recent Developments and Future Plans
Table 39. L.G.C Biosearch Technologies Company Information, Head Office, and Major Competitors
Table 40. L.G.C Biosearch Technologies Major Business
Table 41. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 42. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. L.G.C Biosearch Technologies Recent Developments and Future Plans
Table 44. Integrated DNA Technologies Company Information, Head Office, and Major Competitors
Table 45. Integrated DNA Technologies Major Business
Table 46. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 47. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Integrated DNA Technologies Recent Developments and Future Plans
Table 49. Bio-synthesis Inc. Company Information, Head Office, and Major Competitors
Table 50. Bio-synthesis Inc. Major Business
Table 51. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 52. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Bio-synthesis Inc. Recent Developments and Future Plans
Table 54. metabion Company Information, Head Office, and Major Competitors
Table 55. metabion Major Business
Table 56. metabion Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 57. metabion Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. metabion Recent Developments and Future Plans
Table 59. QIAGEN Company Information, Head Office, and Major Competitors
Table 60. QIAGEN Major Business
Table 61. QIAGEN Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 62. QIAGEN Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. QIAGEN Recent Developments and Future Plans
Table 64. Hongene Company Information, Head Office, and Major Competitors
Table 65. Hongene Major Business
Table 66. Hongene Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 67. Hongene Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Hongene Recent Developments and Future Plans
Table 69. Synthgene Company Information, Head Office, and Major Competitors
Table 70. Synthgene Major Business
Table 71. Synthgene Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 72. Synthgene Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Synthgene Recent Developments and Future Plans
Table 74. Global Nucleic Acids for Molecular Diagnosis Revenue (USD Million) by Players (2020-2025)
Table 75. Global Nucleic Acids for Molecular Diagnosis Revenue Share by Players (2020-2025)
Table 76. Breakdown of Nucleic Acids for Molecular Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Nucleic Acids for Molecular Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 78. Head Office of Key Nucleic Acids for Molecular Diagnosis Players
Table 79. Nucleic Acids for Molecular Diagnosis Market: Company Product Type Footprint
Table 80. Nucleic Acids for Molecular Diagnosis Market: Company Product Application Footprint
Table 81. Nucleic Acids for Molecular Diagnosis New Market Entrants and Barriers to Market Entry
Table 82. Nucleic Acids for Molecular Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Nucleic Acids for Molecular Diagnosis Consumption Value (USD Million) by Type (2020-2025)
Table 84. Global Nucleic Acids for Molecular Diagnosis Consumption Value Share by Type (2020-2025)
Table 85. Global Nucleic Acids for Molecular Diagnosis Consumption Value Forecast by Type (2026-2031)
Table 86. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025)
Table 87. Global Nucleic Acids for Molecular Diagnosis Consumption Value Forecast by Application (2026-2031)
Table 88. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 89. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 90. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 91. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 92. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 95. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 96. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 97. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 98. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 99. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 100. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 101. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 102. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 105. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 106. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 107. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 108. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 109. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 110. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 111. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 113. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 114. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 115. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 116. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 117. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Global Key Players of Nucleic Acids for Molecular Diagnosis Upstream (Raw Materials)
Table 119. Global Nucleic Acids for Molecular Diagnosis Typical Customers
Table 1. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 6. Danaher Corporation Major Business
Table 7. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 8. Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Danaher Corporation Recent Developments and Future Plans
Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
Table 11. Merck KGaA Major Business
Table 12. Merck KGaA Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 13. Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Merck KGaA Recent Developments and Future Plans
Table 15. Eurofins Scientific SE Company Information, Head Office, and Major Competitors
Table 16. Eurofins Scientific SE Major Business
Table 17. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 18. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 20. Thermo Fisher Scientific Inc. Major Business
Table 21. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 22. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 24. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 25. Agilent Technologies, Inc. Major Business
Table 26. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 27. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 29. Kaneka Eurogentec S.A. Company Information, Head Office, and Major Competitors
Table 30. Kaneka Eurogentec S.A. Major Business
Table 31. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 32. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Kaneka Eurogentec S.A. Recent Developments and Future Plans
Table 34. Aji Bio-Pharma Company Information, Head Office, and Major Competitors
Table 35. Aji Bio-Pharma Major Business
Table 36. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 37. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Aji Bio-Pharma Recent Developments and Future Plans
Table 39. L.G.C Biosearch Technologies Company Information, Head Office, and Major Competitors
Table 40. L.G.C Biosearch Technologies Major Business
Table 41. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 42. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. L.G.C Biosearch Technologies Recent Developments and Future Plans
Table 44. Integrated DNA Technologies Company Information, Head Office, and Major Competitors
Table 45. Integrated DNA Technologies Major Business
Table 46. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 47. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Integrated DNA Technologies Recent Developments and Future Plans
Table 49. Bio-synthesis Inc. Company Information, Head Office, and Major Competitors
Table 50. Bio-synthesis Inc. Major Business
Table 51. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 52. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Bio-synthesis Inc. Recent Developments and Future Plans
Table 54. metabion Company Information, Head Office, and Major Competitors
Table 55. metabion Major Business
Table 56. metabion Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 57. metabion Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. metabion Recent Developments and Future Plans
Table 59. QIAGEN Company Information, Head Office, and Major Competitors
Table 60. QIAGEN Major Business
Table 61. QIAGEN Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 62. QIAGEN Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. QIAGEN Recent Developments and Future Plans
Table 64. Hongene Company Information, Head Office, and Major Competitors
Table 65. Hongene Major Business
Table 66. Hongene Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 67. Hongene Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Hongene Recent Developments and Future Plans
Table 69. Synthgene Company Information, Head Office, and Major Competitors
Table 70. Synthgene Major Business
Table 71. Synthgene Nucleic Acids for Molecular Diagnosis Product and Solutions
Table 72. Synthgene Nucleic Acids for Molecular Diagnosis Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Synthgene Recent Developments and Future Plans
Table 74. Global Nucleic Acids for Molecular Diagnosis Revenue (USD Million) by Players (2020-2025)
Table 75. Global Nucleic Acids for Molecular Diagnosis Revenue Share by Players (2020-2025)
Table 76. Breakdown of Nucleic Acids for Molecular Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Nucleic Acids for Molecular Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 78. Head Office of Key Nucleic Acids for Molecular Diagnosis Players
Table 79. Nucleic Acids for Molecular Diagnosis Market: Company Product Type Footprint
Table 80. Nucleic Acids for Molecular Diagnosis Market: Company Product Application Footprint
Table 81. Nucleic Acids for Molecular Diagnosis New Market Entrants and Barriers to Market Entry
Table 82. Nucleic Acids for Molecular Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Nucleic Acids for Molecular Diagnosis Consumption Value (USD Million) by Type (2020-2025)
Table 84. Global Nucleic Acids for Molecular Diagnosis Consumption Value Share by Type (2020-2025)
Table 85. Global Nucleic Acids for Molecular Diagnosis Consumption Value Forecast by Type (2026-2031)
Table 86. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025)
Table 87. Global Nucleic Acids for Molecular Diagnosis Consumption Value Forecast by Application (2026-2031)
Table 88. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 89. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 90. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 91. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 92. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 95. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 96. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 97. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 98. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 99. Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 100. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 101. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 102. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2025) & (USD Million)
Table 105. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2026-2031) & (USD Million)
Table 106. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 107. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 108. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 109. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 110. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 111. South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2025) & (USD Million)
Table 113. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2026-2031) & (USD Million)
Table 114. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2025) & (USD Million)
Table 115. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2026-2031) & (USD Million)
Table 116. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2025) & (USD Million)
Table 117. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Global Key Players of Nucleic Acids for Molecular Diagnosis Upstream (Raw Materials)
Table 119. Global Nucleic Acids for Molecular Diagnosis Typical Customers
LIST OF FIGURES
Figure 1. Nucleic Acids for Molecular Diagnosis Picture
Figure 2. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type in 2024
Figure 4. DNA Series
Figure 5. RNA Series
Figure 6. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application in 2024
Figure 8. Infectious Diseases Picture
Figure 9. Early Cancer Screening Picture
Figure 10. Blood Screening Picture
Figure 11. Genetic Diseases Picture
Figure 12. Genome Sequencing Picture
Figure 13. Other Picture
Figure 14. Global Nucleic Acids for Molecular Diagnosis Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Nucleic Acids for Molecular Diagnosis Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Nucleic Acids for Molecular Diagnosis Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Region in 2024
Figure 19. North America Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Nucleic Acids for Molecular Diagnosis Revenue Share by Players in 2024
Figure 26. Nucleic Acids for Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Nucleic Acids for Molecular Diagnosis by Player Revenue in 2024
Figure 28. Top 3 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
Figure 29. Top 6 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
Figure 30. Global Nucleic Acids for Molecular Diagnosis Consumption Value Share by Type (2020-2025)
Figure 31. Global Nucleic Acids for Molecular Diagnosis Market Share Forecast by Type (2026-2031)
Figure 32. Global Nucleic Acids for Molecular Diagnosis Consumption Value Share by Application (2020-2025)
Figure 33. Global Nucleic Acids for Molecular Diagnosis Market Share Forecast by Application (2026-2031)
Figure 34. North America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 44. France Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 51. China Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 54. India Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 68. Nucleic Acids for Molecular Diagnosis Market Drivers
Figure 69. Nucleic Acids for Molecular Diagnosis Market Restraints
Figure 70. Nucleic Acids for Molecular Diagnosis Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Nucleic Acids for Molecular Diagnosis Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Nucleic Acids for Molecular Diagnosis Picture
Figure 2. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type in 2024
Figure 4. DNA Series
Figure 5. RNA Series
Figure 6. Global Nucleic Acids for Molecular Diagnosis Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application in 2024
Figure 8. Infectious Diseases Picture
Figure 9. Early Cancer Screening Picture
Figure 10. Blood Screening Picture
Figure 11. Genetic Diseases Picture
Figure 12. Genome Sequencing Picture
Figure 13. Other Picture
Figure 14. Global Nucleic Acids for Molecular Diagnosis Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Nucleic Acids for Molecular Diagnosis Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Market Nucleic Acids for Molecular Diagnosis Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 17. Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 18. Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Region in 2024
Figure 19. North America Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 20. Europe Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 21. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 22. South America Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 23. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 24. Company Three Recent Developments and Future Plans
Figure 25. Global Nucleic Acids for Molecular Diagnosis Revenue Share by Players in 2024
Figure 26. Nucleic Acids for Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 27. Market Share of Nucleic Acids for Molecular Diagnosis by Player Revenue in 2024
Figure 28. Top 3 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
Figure 29. Top 6 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
Figure 30. Global Nucleic Acids for Molecular Diagnosis Consumption Value Share by Type (2020-2025)
Figure 31. Global Nucleic Acids for Molecular Diagnosis Market Share Forecast by Type (2026-2031)
Figure 32. Global Nucleic Acids for Molecular Diagnosis Consumption Value Share by Application (2020-2025)
Figure 33. Global Nucleic Acids for Molecular Diagnosis Market Share Forecast by Application (2026-2031)
Figure 34. North America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 35. North America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 36. North America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 41. Europe Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 42. Europe Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 43. Germany Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 44. France Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 45. United Kingdom Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 46. Russia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 47. Italy Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 48. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 49. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 50. Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Region (2020-2031)
Figure 51. China Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 52. Japan Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 53. South Korea Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 54. India Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 55. Southeast Asia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 56. Australia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 57. South America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 58. South America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 59. South America Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 60. Brazil Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 61. Argentina Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 62. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type (2020-2031)
Figure 63. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2031)
Figure 64. Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Country (2020-2031)
Figure 65. Turkey Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 66. Saudi Arabia Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 67. UAE Nucleic Acids for Molecular Diagnosis Consumption Value (2020-2031) & (USD Million)
Figure 68. Nucleic Acids for Molecular Diagnosis Market Drivers
Figure 69. Nucleic Acids for Molecular Diagnosis Market Restraints
Figure 70. Nucleic Acids for Molecular Diagnosis Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Nucleic Acids for Molecular Diagnosis Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
